The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

Natural killer (NK) cells are critical innate immune effector cells but during chronic inflammatory contexts their function and fitness may become impaired. Here the authors implicate the cytokine ...

The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...

Juvenile idiopathic arthritis (JIA), a type of arthritis commonly occurring in children, is a chronic, inflammatory condition ...

The Business Research Company's Stem Cell Umbilical Cord Blood Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034) It will grow to $15.21 billion in 2029 at a compound annual ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

INmune Bio's ATM offering raises $19M ahead of Phase II results, but disappointing data and dilution signal risks. Read here ...

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...